Kennedy Krieger Institute
http://www.kennedykrieger.org
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Kennedy Krieger Institute
Tech Transfer Roundup: Boehringer Teams Up With A*STAR On Targeted Oncology R&D
National Resilience, Parker Institute team to incubate cancer startups. Metropolitan AntiViral Drug Accelerator will focus on eight molecular features of SARS-CoV-2 to create novel oral antivirals.
Neurotech SA
Neurotech is making use of the angiogenic properties of tumors to eradicate them. Beyond brain tumors, Neurotech is targeting other conditions where angiogenesis is important, for example, ischemic stroke. Neuortech's approach is also suited to a variety of other neurological disorders, including Alzheimer's disease and Parkinson's disease.
Company Information
- Industry
- Academic and Research Institutions
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice